University of Groningenfounded in 1614  -  top 100 university
Close
Research Research database

Pharmacotherapy and Pharmaceutical Care

University of Groningen > Faculty of Science and Engineering > Faculty Board FSE > FSE Research > Groningen Research Institute of Pharmacy > Pharmacotherapy and Pharmaceutical Care

Advanced
Advanced

Reset

to
251 - 300 out of 1,207Page size: 50
  1. 2014
  2. Rolfes, L., Wilkes, S., van Hunsel, F., van Puijenbroek, E., & van Grootheest, K. (2014). Important information regarding reporting of adverse drug reactions: a qualitative study. International Journal of Pharmacy Practice (IJPP), 22(3), 231-233. https://doi.org/10.1111/ijpp.12056
  3. Geurts, M. M. E., Zuydgeest, I. A., Walser, S., Kijlstra, N. B., Petkova, V., & de Gier, J. J. (2014). The evaluation of patient self-completion concordance forms used in community pharmacy: A comparison of two European countries. International Journal of Pharmacy Practice (IJPP), 22(3), 186-192. https://doi.org/10.1111/ijpp.12055
  4. Wieringa, A., Boslooper, K., Hoogendoorn, M., Joosten, P., Beerden, T., Storm, H., Kibbelaar, R. E., Veldhuis, G. J., van Kamp, H., van Rees, B., Kluin-Nelemans, H. C., Veeger, N. J. G. M., & van Roon, E. N. (2014). Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study. British Journal of Haematology, 165(4), 489-496. https://doi.org/10.1111/bjh.12765
  5. Daud, A. N. A., Bergman, J. E. H., Bakker, M. K., Wang, H., de Walle, H. E. K., Plosch, T., & Wilffert, B. (2014). Pharmacogenetics of drug-induced birth defects: the role of polymorphisms of placental transporter proteins. Pharmacogenomics, 15(7), 1029-1041. https://doi.org/10.2217/pgs.14.62
  6. Loonen, A., & Wilffert, B. (2014). Regelgeving belemmert behandeling psychiatrische patiënt. Beter: Functionele indicatie vermelden op het recept. Pharmaceutische Weekblad Wetenschappelijk Platform, 149(17), 22-24.
  7. Ivanova, S. A., Geers, L. M., Al Hadithy, A. F. Y., Pechlivanoglou, P., Semke, A. V., Vyalova, N. M., Rudikov, E. V., Fedorenko, O. Y., Wilffert, B., Bokhan, N. A., Brouwers, J. R. B. J., & Loonen, A. J. M. (2014). Dehydroepiandrosterone sulphate as a putative protective factor against tardive dyskinesia. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 50, 172-177. https://doi.org/10.1016/j.pnpbp.2013.12.015
  8. Van Hasselt, F. M., Oud, M. J. T., Krabbe, P. F. M., Postma, M. J., & Loonen, A. J. M. (2014). Improving somatic health of outpatients with severe mental illness. Schizophrenia Research, 153(Supplement 1), S186-S187.
  9. Berm, E. J. J., Brummel-Mulder, E., Paardekooper, J., Hak, E., Wilffert, B., & Maring, J. G. (2014). Determination of venlafaxine and O-desmethylvenlafaxine in dried blood spots for TDM purposes, using LC-MS/MS. Analytical and Bioanalytical Chemistry, 406(9-10), 2349-2353. https://doi.org/10.1007/s00216-014-7619-9
  10. Terwisscha Van Scheltinga, A., Lub-de Hooge, M. N., Hinner, M. J., Verheijen, R. B., Allersdorfer, A., Hulsmeyer, M., Nagengast, W. B., Schroder, C. P., Kosterink, J. G. W., de Vries, E. G. E., Audoly, L., & Olwill, S. A. (2014). In Vivo Visualization of MET Tumor Expression and Anticalin Biodistribution with the MET-Specific Anticalin Zr-89-PRS-110 PET Tracer. Journal of Nuclear Medicine, 55(4), 665-671. https://doi.org/10.2967/jnumed.113.124941
  11. Härmark, L. V. D., Huls, H. J., de Gier, J. J. H., & van Grootheest, A. C. K. (2014). Non-response in a pharmacy and patient-based intensive monitoring system: a quantitative study on non-response bias and reasons for non-response. International Journal of Pharmacy Practice (IJPP), 22(2), 159-162. https://doi.org/10.1111/ijpp.12038
  12. Ottenbros, S., Teichert, M., de Groot, R., Griens, F., Sodihardjo, F., Wensing, M., & de Gier, J. J. (2014). Pharmacist-led intervention study to improve drug therapy in asthma and COPD patients. International Journal of Clinical Pharmacy, 36(2), 336-344. https://doi.org/10.1007/s11096-013-9887-4
  13. Vu, D., Koster, R. A., Bolhuis, M., Greijdanus, B., Altena, R. V., Nguyen, D. H., Brouwers, J., Uges, D., & Alffenaar, J-W. (2014). Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC-MS/MS. Talanta, 121, 9-17. https://doi.org/10.1016/j.talanta.2013.12.043
  14. Nguyen, H., Pham, H-T., Vo, D-K., Nguyen, T-D., van den Heuvel, E. R., Haaijer-Ruskamp, F. M., & Taxis, K. (2014). The effect of a clinical pharmacist-led training programme on intravenous medication errors: a controlled before and after study. BMJ Quality & Safety, 23(4), 319-324. https://doi.org/10.1136/bmjqs-2013-002357
  15. Helmons, P. J., Kosterink, J. G. W., & Daniels, C. E. (2014). Formulary compliance and pharmacy labor costs associated with systematic formulary management strategy. American Journal of Health-System Pharmacy, 71(5), 407-415. https://doi.org/10.2146/ajhp130219
  16. Alsaad, N., Wilffert, B., van Altena, R., de Lange, W. C. M., van der Werf, T. S., Kosterink, J. G. W., & Alffenaar, J-W. C. (2014). Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis. European Respiratory Journal, 43, 884-897. https://doi.org/10.1183/09031936.00113713
  17. Loonen, A. J. M. (2014). Improving somatic health in severe mental illness Reply. Acta Psychiatrica Scandinavica, 129(3), 237-237. https://doi.org/10.1111/acps.12237
  18. Boslooper, K., Kibbelaar, R., Storm, H., Veeger, N. J. G. M., Hovenga, S., Woolthuis, G., van Rees, B., de Graaf, E., van Roon, E., Kluin-Nelemans, H. C., Joosten, P., & Hoogendoorn, M. (2014). Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: a population-based cohort study on treatment, toxicity and outcome. Leukemia and Lymphoma, 55(3), 526-532. https://doi.org/10.3109/10428194.2013.810737
  19. Bijlsma, M. J., Oortgiesen, B. E., Beernink, R. H. J., Bos, J., Wilffert, B., & Hak, E. (2014). Het effect van de CBG-waarschuwing op de trend in SSRI-gebruik in Nederland van 1998 tot 2010. Pharmaceutisch Weekblad Wetenschappelijk Platform, 149(8), 32-36.
  20. Wouters, H., Bouvy, M. L., Van Geffen, E. C., Gardarsdottir, H., Stiggelbout, A. M., & Van Dijk, L. (2014). Antidepressants in primary care: patients' experiences, perceptions, self-efficacy beliefs, and nonadherence. Patient Preference and Adherence, 2014(8), 179-190. https://doi.org/10.2147/PPA.S53748
  21. Yska, J. P., Van Der Meer, D. H., Eilander, W., Dreijer, A. R., Apers, J. A., Emous, M., Totté, E. R. E., Wilffert, B., & Van Roon, E. N. (2014). Influence of bariatric surgery on the use of some major drug classes. Naunyn-Schmiedeberg's Archives of Pharmacology, 387(1), S22-S23. https://doi.org/10.1007/s00210-014-0960-x
  22. van Wanrooy, M. J. P., Rodgers, M. G. G., Uges, D. R. A., Arends, J. P., Zijlstra, J. G., Werf, van der, T. S., Kosterink, J. G. W., & Alffenaar, J-W. C. (2014). Low but Sufficient Anidulafungin Exposure in Critically Ill Patients. Antimicrobial Agents and Chemotherapy, 58(1), 304-308. https://doi.org/10.1128/AAC.01607-13
  23. Wieringa, A., Bethlehem, C., Hoogendoorn, M., van der Maten, J., & van Roon, E. N. (2014). Very late recovery of dapsone-induced methemoglobinemia. Clinical Toxicology, 52(1), 80-81. https://doi.org/10.3109/15563650.2013.864394
  24. Wilffert, B. (2014). Alternatieve geneesmiddelen, een factor van belang bij chemotherapie. Pharmaceutische Weekblad Wetenschappelijk Platform, 8(E1416), 130.
  25. Leendertse, A., de Gier, H., Zwart, D., & de Wit. , N. (2014). Apotheker moet eerstelijns zorgverlener worden. Apotheker en huisarts onder één dak voorkomt veel medicatiefouten. Medisch Contact, 11, 2514-15.
  26. Ekhart, G. C., & van Puijenbroek, E. P. (2014). Blijvende seksuele functiestoornissen na staken van een SSRI? Tijdschrift voor Psychiatrie, 56(5), 336-340.
  27. de Gier, H., & Borgsteede, S. (2014). Commentaren Medicatiebewaking 2014/2015. Stichting Health Base: Houten.
  28. Heringa , M., & de Gier, H. (2014). Contra-indicatie Verkeersdeelname. In JJ. de Gier, & S. Borgsteede (Eds.), Commentaren Medicatiebewaking 2014/2015 (pp. 1126-1144). Stichting Health Base: Houten.
  29. Wilffert, B. (2014). De apotheker, geneesmiddeldeskundige bij uitstek. Pharmaceutische Weekblad Wetenschappelijk Platform, 8(E1427), 173.
  30. Wouters, H., Quik, E. H., Boersma, F., Nygard, P., Bosman, J., Bottger, W. M., Mulder, H., Maring, J-G., Wijma-Vos, L., Beerden, T., van Doormaal, J., Postma, M. J., Zuidema, S. U., & Taxis, K. (2014). Discontinuing Inappropriate Medication in Nursing Home Residents (DIM-NHR Study): Protocol of a cluster randomised controlled trial. BMJ Open, 4(10), [e006082]. https://doi.org/10.1136/bmjopen-2014-006082
  31. Monteiro, S. P. (2014). Driving-impairing medicines and traffic safety. [S.n.].
  32. Van Hasselt, F., Oud, M., Krabbe, P., Postma, M., & Loonen, A. (2014). EPA-0301 – Improving somatic health of outpatients with severe mental illness. European Psychiatry, 29(Supplement 1), [EPA-0301]. https://doi.org/10.1016/S0924-9338(14)77744-2
  33. Nguyen, H., Nguyen, T-D., Haaijer-Ruskamp, F. M., & Taxis, K. (2014). Errors in Preparation and Administration of Insulin in Two Urban Vietnamese Hospitals An Observational Study. Nursing Research, 63(1), 68-72. https://doi.org/10.1097/NNR.0000000000000010
  34. Van Hunsel, F. P. A. M., Kant, A. C., & Van Puijenbroek, E. P. (2014). FARMACOTHERAPIE Trombose en embolie bij gebruik van Diane-35 analyse van meldingen bij Lareb. Nederlands Tijdschrift voor Geneeskunde, 158(21).
  35. Loonen, A. J. M. (2014). Geneesmiddelen en de neurobiologie van de seksuele functies. Foliolum, 28(2), 6-9.
  36. Terwisscha Van Scheltinga, A. G. T., Lub-de Hooge, M. N., Abiraj, K., Schroder, C. P., Pot, L., Bossenmaier, B., Thomas, M., Holzlwimmer, G., Friess, T., Kosterink, J. G. W., & de Vries, L. (2014). ImmunoPET and biodistribution with human epidermal growth factor receptor 3 targeting antibody Zr-89-RG7116. mAbs, 6(4), 1051-1058. https://doi.org/10.4161/mabs.29097
  37. Wilffert, B., Sven, H., Mulder, RHN., van Schaik, M., Nijenhuis, L., Grandia, AH., Maitland-Van der Zee, GA., Rongen, T., Schalekamp, J., van der Weide, A., de Boer, H-J., Guchelaar, DJ., Touw, D., & Deneer, VHM. (2014). Implementation of Pharmacogenetics in Evidence-Based Medicine: Toward Advancing Personalized Medicine: Chapter 22. . In I. S. Vizirianakis (Ed.), Handbook of personalized medicine. Advances in Nanotechnology, Drug Delivery, and Theory (pp. 953-1116). Pan Stanford Publishing.
  38. Bulajeva, A., Labberton, L., Leikola, S., Pohjanoksa-Mäntylä, M., Geurts, M. M. E., de Gier, J. J., & Airaksinen, M. (2014). Medication review practices in European countries. Research in Social and Administrative Pharmacy, 10(5), 731-740. https://doi.org/10.1016/j.sapharm.2014.02.005
  39. Nguyen, H. (2014). Medication safety in Vietnamese hospitals: A focus on medication errors and safety culture. [S.n.].
  40. Wilffert, B. (2014). Naar een duurzaam systeem voor geneesmiddelontwikkeling. Pharmaceutische Weekblad Wetenschappelijk Platform, 8(E1419), 152.
  41. Azim, A., & Wilffert, B. (2014). Nut van genotypering CYP2D6 bij postmenopauzale borstkankerpatiënten behandeld met tamoxifen. MFM-Tijdschrift over praktijkgerichte farmacotherapie, 36-9.
  42. Schaafsma, E. S., van Welie, S. K. A., Pras, N., van Hulten, R. P., & Taxis, K. (2014). Pharmacy Practice Research Internship - An Innovative Approach Linking Practice, Research and Teaching. Research in Social and Administrative Pharmacy, 10(5), E42-E43.
  43. van Hasselt, F. M., Coehorst, Y., Verheijen-Breemhaar, D., Feenstra, B., & Loonen, A. J. M. (2014). Tbc bij een vrouw met een ernstige psychiatrische aandoening. Tijdschrift voor Psychiatrie, 56(1), 50-53.
  44. van Hunsel, F. P. A. M., Kant, A. C., & van Puijenbroek, E. P. (2014). Trombose en embolie bij gebruik van Diane-35: Analyse van meldingen bij Lareb. Nederlands Tijdschrift voor Geneeskunde, 158, [A6651].
  45. 2013
  46. Bolhuis, M. S., van Altena, R., van Soolingen, D., de Lange, W. C. M., Uges, D. R. A., van der Werf, T. S., Kosterink, J. G. W., & Alffenaar, J-W. C. (2013). Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients. European Respiratory Journal, 42(6), 1614-1621. https://doi.org/10.1183/09031936.00001913
  47. Dreischulte, T., Johnson, J., McAnaw, J., Geurts, M., de Gier, H., & Hudson, S. (2013). Medication assessment tool to detect care issues from routine data: a pilot study in primary care. International Journal of Clinical Pharmacy, 35(6), 1063-1074. https://doi.org/10.1007/s11096-013-9828-2
  48. Mol, P. G. M., Van Den Bemt, P. M. L. A., Dequito, A. B., Van Doormaal, J. E., Zaal, R. J., Haaijer-Ruskamp, F. M., & Kosterink, J. G. W. (2013). Vermijdbare en niet-vermijdbare medicatiegerelateerde schade in het ziekenhuis. Pharmaceutische Weekblad Wetenschappelijk Platform, 148(46), 136-142. [a1331]. http://www.pw.nl/archief/wp/2013wp11/a1331
  49. Rolfes, L., Lokhorst, B., Samijn, J., & van Puijenbroek, E. (2013). Cervical dysplasia associated with the use of natalizumab. Netherlands Journal of Medicine, 71(9), 494-495.
  50. van Hasselt, F. M., Oud, M. J. T., & Loonen, A. J. M. (2013). Improvement of care for the physical health of patients with severe mental illness: a qualitative study assessing the view of patients and families. BMC Health Services Research, 13, [426]. https://doi.org/10.1186/1472-6963-13-426
  51. Risselada, A., & Van Roon, E. (2013). Cardiovascular risk in chronic use of high doses. Paracetamol: A wolf in sheep's clothing. Pharmaceutisch Weekblad, 148(40-41), 18-21.
  52. Risselada, A., & Van Roon, E. (2013). Paracetamol: A wolf in sheep's clothing. Cardiovascular risk in chronic use of high doses. Pharmaceutische Weekblad Wetenschappelijk Platform, 148(40-41).
Previous 12 3 4 5 6 7 8 9 ...25 Next

ID: 32723

University of Groningen staff: edit these data

print
Follow the UGfacebook twitter linkedin rss instagram youtube